Pfizer Inc (PFE) - Oncology Revenue (DISCONTINUED) (I:PIPFEOR)
Level Chart
Basic Info
|
Pfizer Inc (PFE) - Oncology Revenue is at a current level of 12.13B, down from 12.33B one year ago. This is a change of -1.63% from one year ago. |
|
Oncology Revenue refers to the sales of various cancer therapies and medications. These could include chemotherapy drugs, targeted therapies, immunotherapies, and other treatments designed to combat various types of cancer. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 12.13B |
| Latest Period | 2022 |
| Last Updated | Oct 5 2023, 11:15 EDT |
| Average Growth Rate | -1.63% |
| Value from 1 Year Ago | 12.33B |
| Change from 1 Year Ago | -1.63% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| December 31, 2022 | 12.13B |
| December 31, 2021 | 12.33B |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Basic Info
|
Pfizer Inc (PFE) - Oncology Revenue is at a current level of 12.13B, down from 12.33B one year ago. This is a change of -1.63% from one year ago. |
|
Oncology Revenue refers to the sales of various cancer therapies and medications. These could include chemotherapy drugs, targeted therapies, immunotherapies, and other treatments designed to combat various types of cancer. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 12.13B |
| Latest Period | 2022 |
| Last Updated | Oct 5 2023, 11:15 EDT |
| Average Growth Rate | -1.63% |
| Value from 1 Year Ago | 12.33B |
| Change from 1 Year Ago | -1.63% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |